Julieta Politi


Email: This email address is being protected from spambots. You need JavaScript enabled to view it.

Social: linkedin logo











Julieta received an MD from the University of Buenos Aires, an MPH from the Universidad Pompeu Fabra. She completed her PhD with a “Rio Hortega” scholarship at the Instituto de Salud Carlos III (ISCIII) and the Universidad Autónoma de Madrid. She completed two medical trainings (Internal Medicine and Preventive Medicine & Public Health). Her academic training and research experience have provided her with an excellent background in multiple disciplines, including translational research in cancer resistance to targeted therapeutics (hematopoietic malignancies), evaluation of population-based cancer screening programs, epidemiology and surveillance of infectious and chronic diseases, epidemiology and surveillance of drug and alcohol use, and evaluation of harm reduction programs. She assisted in the COVID-19 response as a public health officer for Barcelona, Spain. Most recently, she evaluated the public health impact of free and unrestricted access to direct-acting antivirals (DAAs) for hepatitis C as part of the Plan to eliminate Hepatitis C in Spain.

Her research interests include infectious disease epidemiology, the epidemiology of alcohol & drug use and its consequences, chronic liver diseases, cancer epidemiology, the evaluation of public health interventions, and socioeconomic inequalities in health.


Pulido J, Barrio G, Donat M, Politi J, Moreno A, Cea-Soriano L, Guerras JM, Huertas L, Mateo-Urdiales A, Ronda E, Martínez D, Lostao L, Belza MJ, Regidor E. Excess Mortality During 2020 in Spain: The Most Affected Population, Age, and Educational Group by the COVID-19 Pandemic. Disaster Med Public Health Prep. 2024 Feb 19;18:e27. doi: 10.1017/dmp.2024.17. PMID: 38372080.

Politi J, Donat M, Guerras JM, Ayerdi O, Palma D, García JN, Barrio G, Belza MJ; Methysos Project Group. Gaps in HIV and Hepatitis C Testing Among 3486 HIV-Negative Men Who Have Sex with Men in Spain in the Era of Highly Effective Antiviral Therapies. J Community Health. 2024 Feb;49(1):139-155. doi: 10.1007/s10900-023-01259-9. Epub 2023 Aug 10. PMID: 37561245.

Donat M, Regidor E, Barrio G, Ambrosio E, Sordo L, Guerras JM, Politi J, Belza MJ. Increase in educational inequalities in alcohol-related mortality in Spain during a period of economic growth. Addiction. 2023 Oct;118(10):1920-1931. doi: 10.1111/add.16264. Epub 2023 Jun 5. PMID: 37203875.

Pérez-Romero C, Barrio G, Hoyos J, Belza MJ, Regidor E, Donat M, Politi J, Guerras JM, Pulido J. Abrupt peaks in perceived risk of occasional drug use after changing the question order in a repeated self-administered survey. Front Public Health. 2023 Apr 14;11:971239. doi: 10.3389/fpubh.2023.971239. PMID: 37124773; PMCID: PMC10140628.

Politi J, Regidor E, Donat M, Pulido J, Guerras JM, Barrio G, Belza MJ. Free Access to Direct-Acting Antivirals in Spain: More Favorable Impact on Hepatitis C Mortality Among Highly Educated People. Clin Infect Dis. 2023 Apr 17;76(8):1423-1430. doi: 10.1093/cid/ciac928. PMID: 36471910.

Politi J, Queralt A, Valero N, Martín-Gómez MT, Durán RG, Parra E, Camps SS, Avellanés I, Hernández-Pineda A, Masdeu E, Rius C, Álamo-Junquera D. Vehicle Windshield Wiper Fluid as Potential Source of Sporadic Legionnaires' Disease in Commercial Truck Drivers. Emerg Infect Dis. 2022 Apr;28(4):841-843. doi: 10.3201/eid2804.210814. PMID: 35318929; PMCID: PMC8962911.

Politi J, Guerras JM, Donat M, Belza MJ, Ronda E, Barrio G, Regidor E. Favorable impact in hepatitis C-related mortality following free access to direct-acting antivirals in Spain. Hepatology. 2022 May;75(5):1247-1256. doi: 10.1002/hep.32237. Epub 2021 Dec 17. PMID: 34773281.

Álamo-Junquera D, Politi J, Simón P, Dieli-Crimi R, Borrell RP, Colobran R, Martínez-Gallo M, Campins M, Antón A, Esperalba J, Andrés C, Codina MG, Polverino E, Narciso MR, Molinero E, Rius C. Coordinated Response to Imported Vaccine-Derived Poliovirus Infection, Barcelona, Spain, 2019-2020. Emerg Infect Dis. 2021 May;27(5):1513-1516. doi: 10.3201/eid2705.204675. PMID: 33900188; PMCID: PMC8084499.

Politi J, Martín-Sánchez M, Mercuriali L, Borras-Bermejo B, Lopez-Contreras J, Vilella A, Villar J; COVID-19 Surveillance Working Group of Barcelona; Orcau A, de Olalla PG, Rius C. Epidemiological characteristics and outcomes of COVID-19 cases: mortality inequalities by socio-economic status, Barcelona, Spain, 24 February to 4 May 2020. Euro Surveill. 2021 May;26(20):2001138. doi: 10.2807/1560-7917.ES.2021.26.20.2001138. PMID: 34018483; PMCID: PMC8138960.

Donat M, Sordo L, Guerras JM, Politi J, Pulido J, Barrio G. Methodology used to estimate alcohol-attributable mortality in Spain, 2001-2017. Adicciones. 2023 Sep 1;35(3):265-278. English, Spanish. doi: 10.20882/adicciones.1611. PMID: 34171110.

Politi J, Sala M, Domingo L, Vernet-Tomas M, Román M, Macià F, Castells X. Readmissions and complications in breast ductal carcinoma in situ: A retrospective study comparing screen- and non-screen-detected patients. Womens Health (Lond). 2020 Jan-Dec;16:1745506520965899. doi: 10.1177/1745506520965899. PMID: 33076785; PMCID: PMC7594253.

Lasater EA, Massi ES, Stecula A, Politi J, Tan SK, Smith CC, Gunthorpe M, Holmes JP, Chehab F, Sali A, Shah NP. Novel TKI-resistant BCR-ABL1 gatekeeper residue mutations retain in vitro sensitivity to axitinib. Leukemia. 2016 Jun;30(6):1405-9. doi: 10.1038/leu.2015.303. Epub 2015 Oct 29. PMID: 26511402.

Politi J, Shah NP. What does a deep molecular response signify? J Clin Oncol. 2014 Feb 10;32(5):471-4. doi: 10.1200/JCO.2013.52.8307. Epub 2013 Dec 2. PMID: 24297955.